Indonesia DIABETES DRUGS Market Revenue, By Technology, 2024 2032 (USD Million) 95 18.6
Superior and Sustained Performance: Arthramid achieves 80-85% efficacy across multiple peer-reviewed studies Long-lasting Results: Clinical studies demonstrate sustained efficacy up to 2 years post-treatment Evidence-Based Efficacy: Double-blinded controlled studies confirm Arthramid outperforms triamcinolone steroid and hyaluronic acid Proven Safety Profile: Histopathology studies confirm successful joint integration and biocompatibility Robust Research Foundation: Results validated across six independent peer-reviewed studies spanning multiple research teams and geographical locations Unlike many joint treatments on the market, Arthramid is backed by a growing body of robust, real-world research, not just anecdotal outcomes
Shakeel, M
Store the lyophilised powder at 20C
View on PubMed PT-141: A Melanocortin Agonist for the Treatment of Sexual Dysfunction Demonstrated PT-141, a metabolite of Melanotan II, activates MC3R and MC4R to treat both male and female sexual dysfunction, confirming the melanocortin pathway as the mechanism for sexual arousal effects (Ann N Y Acad Sci, 2003)
The use of NAC as a chelator of heavy metals appears to be a promising area of medical research and further clinical studies to verify these preliminary findings are warranted
